Top 10 Healthcare Industry Predictions For 2026
The year 2026 will be a tumultuous period for American healthcare, marked by significant changes and challenges. Here are the top 10 predictions for the industry:
AI Revolution Faces Speed Bumps: The healthcare sector's rapid adoption of AI will encounter obstacles. While AI has shown promise in simple tasks, its application in complex areas will be more challenging. Legacy systems and processes will resist change, and the influx of AI 'snake oil' salespeople may lead to false starts and slow down true organizational transformation.
MAHA Goes Mainstream: The Make American Health Again (MAHA) movement, led by Secretary Robert F. Kennedy Jr., will gain traction. Americans are increasingly dissatisfied with traditional healthcare, favoring prevention and wellness. Direct-to-consumer lab testing and radiologic screening services will become more prominent, and biohacking will gain mainstream acceptance as patients seek alternative care options.
GLP1 Revolution Continues: The GLP1 class of drugs will continue to gain popularity, driven by real-world data and celebrity endorsements. However, safety concerns may arise, and next-generation GLP1 drugs are on the horizon, promising even greater effectiveness.
Medicare Advantage's Resilience: Despite criticism, Medicare Advantage will remain popular due to its lower costs and coverage. Traditional Medicare has become unaffordable for most seniors, making Medicare Advantage a practical choice. However, the program needs improvements to address its flaws.
Patient and Clinician Discontent: Patient and clinician frustration will intensify due to medical debt, surprise billing, insurance denials, and soaring medical costs. Healthcare professionals are also disenchanted with wage stagnation, corporatization, and labor arbitrage. Managing discontent and leading change will be crucial for healthcare leaders.
Small Guys Continue to Lose: National and regional health plans, including state-based Blue Cross Blue Shield plans, are facing significant losses due to mispricing and reimbursement changes. Consolidation and mergers will become more common as scale becomes critical for survival.
Digital Health IPOs Accelerate: The digital health sector will witness a surge in initial public offerings (IPOs) as venture capital investors seek liquidity. Startups will aim to avoid the digital health graveyard, leading to mergers and acquisitions, despite challenges and insider knowledge.
Pharma Pricing and PBMs in Focus: The pharmaceutical industry and pharmacy benefit managers (PBMs) will face heightened scrutiny over pricing. Public antagonism towards pharma prices will peak, and the industry will need to address public concerns and demonstrate the value of innovations.
Legislative Activity with Limited Action: Congress will see numerous healthcare bills and proposals, but actual legislative changes will be scarce. The political sensitivity of healthcare reform makes it challenging to pass significant changes, despite the desire for reform.
Health Equity's Comeback: Health equity initiatives will regain prominence as the industry recognizes the persistence of health disparities. Addressing the needs of high-needs populations will be seen as good business, and efforts to tackle inequities will make a comeback, despite the absence of the term from public discourse.
In conclusion, 2026 promises to be a year of dramatic change and challenges in American healthcare, with both opportunities and obstacles on the horizon.
